SIRT4 Protects Retina Against Excitotoxic Injury by Promoting OPA1-Mediated Müller Glial Cell Mitochondrial Fusion and GLAST Expression
Investigative Ophthalmology & Visual Science · 2025-01-28 · 66 (1) · 62
DOI: 10.1167/iovs.66.1.62 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2025-01-28. Written by Qian Ying and 9 co-authors. Institution: Affiliated Eye Hospital of Nanchang University, Jiangxi Research Institute of Ophthalmology and Visual Science, Jiangxi Provincial Key Laboratory for…. Major MEDLINE topics: Ependymoglial Cells, Sirtuins, GTP Phosphohydrolases, Mitochondrial Dynamics. Cited 4 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
This study aimed to investigate the role of SIRT4 in retinal protection, specifically its ability to mitigate excitotoxic damage to Müller glial cells through the regulation of mitochondrial dynamics and glutamate transporters (GLASTs).
Methods
A model of retinal excitatory neurotoxicity was established in mice. Proteins related to mitochondrial dynamics, GLAST, and SIRT4 were analyzed on days 0, 1, 3, and 5 following toxic injury. The influence of SIRT4 on mitochondrial dynamics-related proteins and GLAST was examined by inducing SIRT4 overexpression through intraperitoneal injection of resveratrol or by using SIRT4 knockout (KO) mice. Additionally, the effects of upregulating and downregulating SIRT4 expression in rat Müller glial cell lines (rMC-1) were explored via lentiviral vector transfection to assess changes in mitochondrial morphology and GLAST expression.
Results
After excitotoxic injury to the mouse retina, the retinal thickness and structure were disrupted, the number of retinal ganglion cells (RGCs) decreased, and Müller glial cells were activated by day 1. The levels of OPA1, GLAST, and SIRT4 proteins peaked on the first day after injury and then gradually decreased, indicating a synchronized dynamic trend. The upregulation of SIRT4 expression promoted OPA1 and GLAST protein expression, thereby alleviating retinal excitotoxic injury. Furthermore, the upregulation of SIRT4 expression promoted mitochondrial fusion and increased GLAST expression in rMC-1 cells, reducing cellular excitotoxic damage. Conversely, downregulation of SIRT4 had the opposite effect.
Conclusions
SIRT4 plays a significant role in mitigating excitotoxic damage in the retina, modulating Müller glial cell injury by regulating mitochondrial dynamics and glutamate transporter expression, ultimately influencing retinal health.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Affiliated Eye Hospital of Nanchang University, Jiangxi Research Institute of Ophthalmology and Visual Science, Jiangxi Provincial Key Laboratory for Ophthalmology, Jiangxi Clinical Research Center for Ophthalmic Diseas…
- Xingguo Hospital Affiliated to Gannan Medical University, Xingguo, China.
Cite
APA
Ying, Q., Luo, H., Xie, Z., Huang, Y., Hu, H., Jin, M., Xu, K., Pang, Y., Song, Y., & Zhang, X. (2025). SIRT4 Protects Retina Against Excitotoxic Injury by Promoting OPA1-Mediated Müller Glial Cell Mitochondrial Fusion and GLAST Expression. Investigative Ophthalmology & Visual Science, 66(1), 62. https://doi.org/10.1167/iovs.66.1.62
Vancouver
Ying Q, Luo H, Xie Z, Huang Y, Hu H, Jin M, et al. SIRT4 Protects Retina Against Excitotoxic Injury by Promoting OPA1-Mediated Müller Glial Cell Mitochondrial Fusion and GLAST Expression. Investigative Ophthalmology & Visual Science. 2025;66(1):62. doi:10.1167/iovs.66.1.62
BibTeX
@article{Ying2025,
author = {Ying, Qian and Luo, Hongdou and Xie, Zhi and Huang, Yi and Hu, Haijian and Jin, Ming and Xu, Ke and Pang, Yulian and Song, Yuning and Zhang, Xu},
title = {SIRT4 Protects Retina Against Excitotoxic Injury by Promoting OPA1-Mediated Müller Glial Cell Mitochondrial Fusion and GLAST Expression},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {1},
pages = {62},
doi = {10.1167/iovs.66.1.62}
}
EUVIMED